{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:05:23Z","timestamp":1788303923517,"version":"build-2803163510"},"reference-count":210,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T00:00:00Z","timestamp":1505433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jiac.2017.09.002","type":"journal-article","created":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T10:32:07Z","timestamp":1507026727000},"page":"1-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["JAID\/JSC Guidelines for Infection Treatment 2015\u2212Intestinal infections"],"prefix":"10.1016","volume":"24","author":[{"given":"Kenji","family":"Ohnishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ainoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sentaro","family":"Iwabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumi","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2017.09.002_bib1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.7326\/0003-4819-117-3-202","article-title":"Empiric treatment of acute diarrheal disease with norfloxacin: a randomized, placebo-controlled study","volume":"117","author":"Wistr\u00f6m","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/clinids\/22.6.1019","article-title":"Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin","volume":"22","author":"Dryden","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/archinte.1990.00390150047009","article-title":"Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults","volume":"150","author":"Goodman","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib4","first-page":"559","article-title":"Clinical studies of bay o 9867 on Bacillary dysentery","volume":"33","author":"Motohiro","year":"1985","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jiac.2017.09.002_bib5","first-page":"322","article-title":"Comparison of clinical efficacy of ciprofloxacin (CPFX, bay o 9867) and pipemidic acid (PPA) in the treatment of infectious enteritis by a double-blind method","volume":"62","author":"Aoki","year":"1988","journal-title":"J\u00a0Jpn Assoc Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib6","first-page":"659","article-title":"Clinical trial of T-3262 (Tosufloxacin tosilate) on Salmonella enteritis, and fecal drug concentration and change in the fecal microflora in the acute diarrheal patients","volume":"63","author":"Aoki","year":"1989","journal-title":"J\u00a0Jpn Assoc Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib7","first-page":"170","article-title":"Clinical trial of levofloxacin (DR-3355) and fecal drug concentration and change in the fecal microflora in infectious enteritis","volume":"40","author":"Murata","year":"1992","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jiac.2017.09.002_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/318514","article-title":"Practice guidelines for the management of infectious diarrhea","volume":"32","author":"Guerrant","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1056\/NEJMcp031534","article-title":"Clinical practice. Acute infectious diarrhea","volume":"350","author":"Thielman","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib10","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJM200006293422601","article-title":"The risk of the hemolytic\u2013uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections","volume":"342","author":"Wong","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib11","first-page":"1962","article-title":"Guidelines on acute infectious diarrhea in adults. The practice parameters committee of America college of gastroenterology","volume":"92","author":"DuPont","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jiac.2017.09.002_bib12","first-page":"1206","article-title":"Reptile-associated salmonellosis - selected states, 1998-2002","volume":"52","author":"Centers for Disease Control and Prevention","year":"2003","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jiac.2017.09.002_bib13","first-page":"79","article-title":"Notes from the field. Outbreak of salmonellosis associated with pet turtle exposures \u2013 United States, 2011","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jiac.2017.09.002_bib14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0002-9343(00)00638-0","article-title":"The risk of vascular infection in adult patients with nontyphi Salmonella bacteremia","volume":"110","author":"Benenson","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib15","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/513747","article-title":"Focal infections due to non-typhi Salmonella in patients with AIDS: report of 10 cases and review","volume":"25","author":"Fern\u00e1ndez Guerrero","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7326\/0003-4819-114-3-195","article-title":"Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during and outbreak in health care workers","volume":"114","author":"Neill","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib17","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1542\/peds.65.6.1125","article-title":"Treatment of Salmonella gastroenteritis with ampicillin, amoxicillin, or placebo","volume":"65","author":"Nelson","year":"1980","journal-title":"Pediatrics"},{"key":"10.1016\/j.jiac.2017.09.002_bib18","series-title":"Infections of the gastrointestinal tract. New York","first-page":"785","article-title":"Salmonella, including S.typhi","author":"Pegues","year":"1995"},{"key":"10.1016\/j.jiac.2017.09.002_bib19","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/0140-6736(90)92938-E","article-title":"Treatment of multiresistant typhoid fever","volume":"336","author":"Mandal","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2017.09.002_bib20","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/clinids\/9.4.719","article-title":"Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, ceftriaxone, cefoperazone and other newer cephalosporins","volume":"9","author":"Soe","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib21","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJM199805073381901","article-title":"Emergence of multidrug-resistant Salmonella enterica serotype Typhimurium DT104 infections in the United States","volume":"338","author":"Glynn","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib22","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJM200105243442102","article-title":"A\u00a0nosocomial outbreak of fluoroquinolone-resistant Salmonella infection","volume":"344","author":"Olsen","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib23","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1086\/422726","article-title":"Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge","volume":"39","author":"Su","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib24","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1128\/CMR.11.3.555","article-title":"Campylobacter species and Guillain-Barr\u00e9 syndrome","volume":"11","author":"Nachamkin","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2017.09.002_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0891-5520(05)70416-5","article-title":"Campylobacter jejunii infections as a cause of the Gullain-Barr\u00e9 syndrome","volume":"12","author":"Allos","year":"1998","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jiac.2017.09.002_bib26","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM199905203402001","article-title":"Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992\u20131998","volume":"340","author":"Smith","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/dkl210","article-title":"Macrolide resistance in Campylobacter jejuni and Campylobacter coli","volume":"58","author":"Gibreel","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2017.09.002_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(82)90380-4","article-title":"Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis","volume":"1","author":"Anders","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2017.09.002_bib29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/jac\/13.6.619","article-title":"Double-blind placebo-controlled trial of erythromycin in the treatment of clinical Campylobacter infection","volume":"13","author":"Mandal","year":"1984","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2017.09.002_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0022-3476(86)80404-8","article-title":"Early treatment with erythromycin of Campylobacter jejuni\u2013associated dysentery in children","volume":"109","author":"Salazar-Lindo","year":"1986","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jiac.2017.09.002_bib31","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1086\/383473","article-title":"Shiga Toxin\u2014producing Escherichia coli infection","volume":"38","author":"Thorpe","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib32","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1056\/NEJM199508103330608","article-title":"Escherichia coli O157:H7 and the hemolytic-uremic syndrome","volume":"333","author":"Boyce","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/INF.0b013e31823096a8","article-title":"Antibiotic treatment of Escheritica coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota","volume":"31","author":"Smith","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2017.09.002_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/cid\/cis299","article-title":"Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis","volume":"55","author":"Wong","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0022-3476(05)81209-0","article-title":"Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis","volume":"121","author":"Proulx","year":"1992","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jiac.2017.09.002_bib36","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jama.288.8.996","article-title":"Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis","volume":"288","author":"Safdar","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2017.09.002_bib37","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1442-200X.1999.4121038.x","article-title":"Effect of early oral fluoroquinolones in hemorrhagic colitis due to Escherichia coli O157:H7","volume":"41","author":"Shiomi","year":"1999","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jiac.2017.09.002_bib38","first-page":"357","article-title":"Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection","volume":"52","author":"Ikeda","year":"1999","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jiac.2017.09.002_bib39","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1001\/jama.1970.03180100035006","article-title":"Clinical and bacteriological evaluation of antibiotic treatment in shigellosis","volume":"214","author":"Tong","year":"1970","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2017.09.002_bib40","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/infdis\/162.3.711","article-title":"Therapy for shigellosis. II. Randomized, double-blind comparison of ciprofloxacin and ampicillin","volume":"162","author":"Bennish","year":"1990","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib41","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-126-9-199705010-00004","article-title":"Treatment of shigellosis. V. Comparison of azithromycin and ciprofloxacin: a double-blind, randomized, controlled trial","volume":"126","author":"Khan","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib42","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/AAC.43.9.2333","article-title":"Mechanisms of quinolone resistance in clinical isolates of Shigella dysenteriae","volume":"43","author":"Ahamed","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.09.002_bib43","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1128\/AAC.34.5.939","article-title":"Double-blind, randomized, controlled clinical trials of norfloxacin for cholera","volume":"34","author":"Bhattacharya","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.09.002_bib44","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/clinids\/20.6.1485","article-title":"Ciprofloxacin for the treatment of cholera: a randomized, doubleblind, controlled clinical trial of a single daily dose in Peruvian adults","volume":"20","author":"Gotuzzo","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0035-9203(95)90675-4","article-title":"Comparative trial of five antimicrobial compounds in the treatment of cholera in adults","volume":"89","author":"Khan","year":"1995","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"10.1016\/j.jiac.2017.09.002_bib46","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(96)01180-4","article-title":"Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139","volume":"348","author":"Khan","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2017.09.002_bib47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/AAC.39.1.241","article-title":"Survey of in\u00a0vitro susceptibilities of Vibrio cholerae O1 and O139 to antimicrobial agents","volume":"39","author":"Yamamoto","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.09.002_bib48","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMoa054493","article-title":"Single-dose azithromycin for the treatment of cholera in adults","volume":"354","author":"Saha","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib49","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib50","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/bmj.333.7558.78","article-title":"Current concepts in the diagnosis and treatment of typhoid fever","volume":"333","author":"Bhutta ZA","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jiac.2017.09.002_bib51","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/AAC.00447-06","article-title":"Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azythromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever","volume":"51","author":"Parry","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.09.002_bib52","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ijantimicag.2009.12.020","article-title":"Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciplofloxiacin and ceftriaxone","volume":"35","author":"Nath","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2017.09.002_bib53","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1128\/JCM.00648-10","article-title":"First report of Salmonella enterica serotype paratyphi A azithromycin resistance leading to treatment failure","volume":"48","author":"Molloy","year":"2010","journal-title":"J\u00a0Clin Microbil"},{"key":"10.1016\/j.jiac.2017.09.002_bib54","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1469-0691.2009.03099.x","article-title":"European society of clinical microbiology and infectious diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)","volume":"15","author":"Bauer","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2017.09.002_bib55","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jiac.2017.09.002_bib56","doi-asserted-by":"crossref","first-page":"353","DOI":"10.5694\/j.1326-5377.2011.tb03006.x","article-title":"Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection","volume":"194","author":"Cheng","year":"2011","journal-title":"Med J Aust"},{"key":"10.1016\/j.jiac.2017.09.002_bib57","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ajg.2013.4","article-title":"Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections","volume":"108","author":"Surawicz","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jiac.2017.09.002_bib58","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile\u2013more difficult than ever","volume":"359","author":"Kelly","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib59","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1093\/jac\/dkr253","article-title":"Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection","volume":"66","author":"Talpaert","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2017.09.002_bib60","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10156-010-0160-7","article-title":"Chapter 2-12-7. Anaerobic infections (individual fields): antibiotic-associated diarrhea and enterocolitis","volume":"17","author":"Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections","year":"2011","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2017.09.002_bib61","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-145-10-200611210-00008","article-title":"Narrative review: the new epidemic of Clostridium difficile-associated enteric disease","volume":"145","author":"Bartlett","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib62","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/jac\/dkg254","article-title":"Antibiotics and hospital-acquired Clostridium difficile-associated diarrhea: a systematic review","volume":"51","author":"Thomas","year":"2003","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2017.09.002_bib63","first-page":"371","article-title":"Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991","volume":"15","author":"Olson","year":"1994","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jiac.2017.09.002_bib64","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1086\/501989","article-title":"Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea","volume":"23","author":"Kyne","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jiac.2017.09.002_bib65","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ajg.2012.179","article-title":"Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis","volume":"107","author":"Janarthanan","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jiac.2017.09.002_bib66","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ajg.2012.108","article-title":"Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis","volume":"107","author":"Kwok","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jiac.2017.09.002_bib67","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/cid\/cit280","article-title":"Obesity as a risk factor for Clostridium difficile infection","volume":"57","author":"Bishara","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib68","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0002-9343(03)00420-0","article-title":"Clostridium difficile infection in patients with unexplained leukocytosis","volume":"115","author":"Wanahita","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib69","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7883\/yoken.65.326","article-title":"A\u00a0superior test for diagnosis of Clostridium difficile-associated diarrhea in resource-limited settings","volume":"65","author":"Chotiprasitsakul","year":"2012","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib70","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1086\/340536","article-title":"Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by Clostridium difficile","volume":"34","author":"Wanahita","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib71","first-page":"1755","article-title":"Clostridium difficile colitis","volume":"330","author":"Goldman","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib72","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.sla.0000236628.79550.e5","article-title":"Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain","volume":"245","author":"Lamontagne","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.jiac.2017.09.002_bib73","first-page":"147","article-title":"Rapid-tests detection evaluation of Clostridium difficile toxins and microbiological investigation","volume":"84","author":"Nakagawa","year":"2010","journal-title":"J\u00a0Jpn Assoc Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib74","first-page":"513","article-title":"Clostridium difficile TOX A\/B II test evaluation","volume":"83","author":"Sugiura","year":"2009","journal-title":"J\u00a0Jpn Assoc Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib75","first-page":"33","article-title":"Usefulness of immunological detection of both toxin A and toxin B in stool samples for rapid diagnosis of Clostridium difficile-associated diarrhea","volume":"81","author":"Toyokawa","year":"2007","journal-title":"J\u00a0Jpn Assoc Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib76","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1128\/JCM.00032-08","article-title":"Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection","volume":"46","author":"Sloan","year":"2008","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2017.09.002_bib77","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/jcp.50.12.996","article-title":"Evaluation of a new enzyme immunoassay for Clostridium difficile toxin A","volume":"50","author":"Vargas","year":"1997","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jiac.2017.09.002_bib78","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1128\/JCM.01060-08","article-title":"Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens","volume":"46","author":"Alcal\u00e1","year":"2008","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2017.09.002_bib79","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10096-006-0251-7","article-title":"Evaluation of three rapid assays for detection of Clostridium difficile toxin A and toxin B in stool specimens","volume":"26","author":"R\u00fcssmann","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib80","doi-asserted-by":"crossref","first-page":"835","DOI":"10.7326\/0003-4819-123-11-199512010-00004","article-title":"Clostridium difficile colitis: an efficient clinical approach to diagnosis","volume":"123","author":"Manabe","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib81","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-151-3-200908040-00005","article-title":"Does my patient have Clostridium difficile infection?","volume":"151","author":"Peterson","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib82","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/ajg.2009.174","article-title":"Diagnostic value of repeated enzyme immunoassays in Clostridium difficile infection","volume":"104","author":"Nemat","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jiac.2017.09.002_bib83","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7326\/0003-4819-135-6-200109180-00012","article-title":"Fatal pseudomembranous colitis associated with a variant Clostridium difficile strain not detected by toxin A immunoassay","volume":"135","author":"Johnson","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib84","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1128\/JCM.42.8.3837-3840.2004","article-title":"Multicenter evaluation of a new screening test that detects Clostridium difficile in fecal specimens","volume":"42","author":"Zheng","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2017.09.002_bib85","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1128\/JCM.42.10.4863-4865.2004","article-title":"Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C.\u00a0difficile Tox A\/B II EIA kit, the Triage C.\u00a0difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea","volume":"42","author":"Snell","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2017.09.002_bib86","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archinte.1986.00360130117016","article-title":"Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study","volume":"146","author":"Gerding","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib87","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2214\/ajr.176.3.1760635","article-title":"Evaluating the CT diagnosis of Clostridium difficile colitis: should CT guide therapy?","volume":"176","author":"Kirkpatrick","year":"2001","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jiac.2017.09.002_bib88","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1086\/502129","article-title":"Activity of three disinfectants and acidified nitrite against Clostridium difficile spores","volume":"24","author":"Wullt","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jiac.2017.09.002_bib89","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s10156-013-0553-5","article-title":"Antimicrobial susceptibilities of Clostridium difficile isolated in Japan","volume":"19","author":"Kunishima","year":"2013","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2017.09.002_bib90","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/501997","article-title":"SHEA Long-Term-Care Committee. Clostridium difficile in long-term-care facilities for the elderly","volume":"23","author":"Simor","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jiac.2017.09.002_bib91","first-page":"81","article-title":"Comparing ImmunoCard with two EIA assays for Clostridium difficile toxins","volume":"22","author":"Chan","year":"2009","journal-title":"Clin Lab Sci"},{"key":"10.1016\/j.jiac.2017.09.002_bib92","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1086\/655999","article-title":"Detection of Clostridium difficile infection","volume":"31","author":"Bartlett","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jiac.2017.09.002_bib93","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1086\/649213","article-title":"Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality","volume":"50","author":"Miller","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib94","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa051639","article-title":"A\u00a0predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality","volume":"353","author":"Loo","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib95","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/cid\/cis614","article-title":"Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England","volume":"55","author":"Wilcox","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib96","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A\u00a0comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity","volume":"45","author":"Zar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib97","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/clinids\/22.5.813","article-title":"Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea","volume":"22","author":"Wenisch","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib98","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1086\/588293","article-title":"Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin","volume":"47","author":"Al-Nassir","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib99","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004610.pub4","article-title":"Antibiotic treatment for Clostridium difficile-associated diarrhea in adults","volume":"9","author":"Nelson","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jiac.2017.09.002_bib100","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00004836-200405000-00005","article-title":"Factors associated with failure of metronidazole in Clostridium difficile-associated disease","volume":"38","author":"Fernandez","year":"2004","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jiac.2017.09.002_bib101","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1086\/501126","article-title":"Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada","volume":"42","author":"P\u00e9pin","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib102","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1128\/AAC.05647-11","article-title":"Prospective observational study comparing three different treatment regimes in patients with Clostridium difficile infection","volume":"56","author":"Wenisch","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.09.002_bib103","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jhin.2012.12.019","article-title":"Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection","volume":"85","author":"Bass","year":"2013","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.jiac.2017.09.002_bib104","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1572-0241.2002.05839.x","article-title":"Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease","volume":"97","author":"McFarland","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jiac.2017.09.002_bib105","first-page":"867","article-title":"Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis","volume":"80","author":"Tedesco","year":"1985","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jiac.2017.09.002_bib106","series-title":"Manual for the management of severe adverse reactions by the disease Pseudomembranous enteritis","author":"Ministry of Health","year":"2008"},{"key":"10.1016\/j.jiac.2017.09.002_bib107","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/367657","article-title":"Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube","volume":"36","author":"Aas","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib108","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"van Nood","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib109","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/infdis\/jis206","article-title":"The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States","volume":"205","author":"Bresee","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib110","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/aje\/154.7.666","article-title":"Sensor, a population-based cohort study on gastroenteritis in The Netherlands: incidence and etiology","volume":"154","author":"de Wit","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jiac.2017.09.002_bib111","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10096-007-0290-8","article-title":"Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case-control Infectious Intestinal Disease Study (1993-1996)","volume":"26","author":"Amar","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib112","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s10096-009-0729-1","article-title":"Incidence and risk factors for community-acquired acute gastroenteritis in north-west Germany in 2004","volume":"28","author":"Karsten","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib113","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1086\/321875","article-title":"Etiology of gastroenteritis in sentinel general practices in The Netherlands","volume":"33","author":"de Wit","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib114","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s15010-008-8106-z","article-title":"Etiology of acute gastroenteritis in three sentinel general practices, Austria 2007","volume":"37","author":"Huhulescu","year":"2009","journal-title":"Infection"},{"key":"10.1016\/j.jiac.2017.09.002_bib115","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2105\/AJPH.72.12.1329","article-title":"The frequency of a Norwalk-like pattern of illness in outbreaks of acute gastroenteritis","volume":"72","author":"Kalplan","year":"1982","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jiac.2017.09.002_bib116","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1086\/653939","article-title":"Chronic norovirus infection after kidney transplantation: molecular evidence for immune-driven viral evolution","volume":"51","author":"Schorn","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib117","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/TP.0b013e31821c9392","article-title":"Impact of norovirus\/sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea","volume":"92","author":"Roos-Weil","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jiac.2017.09.002_bib118","first-page":"90","article-title":"Guideline for the prevention and control of norovirus gastroentries outbreaks in healthcare settings","volume":"32","author":"MacCannell","year":"2011","journal-title":"Infect Contrl Hosp Epidemiol"},{"key":"10.1016\/j.jiac.2017.09.002_bib119","doi-asserted-by":"crossref","first-page":"783","DOI":"10.7326\/0003-4819-109-10-783","article-title":"Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants","volume":"109","author":"Reed","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib120","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/infdis\/167.2.278","article-title":"Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomized, double-blind, placebo-controlled multicenter study","volume":"167","author":"Dieterich","year":"1993","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib121","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.4269\/ajtmh.1974.23.1000","article-title":"Double blind study with a new nitoroimidazole derivative, Ro 7-0207, versus metronidazole in symptomatic intestinal amebiasis","volume":"23","author":"Botero","year":"1974","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jiac.2017.09.002_bib122","first-page":"9","article-title":"Treatment of intestinal E. histolytica and G. lamblia with metronidazole, tinidazole and ornidazole: a comparative study","volume":"90","author":"Bassily","year":"1987","journal-title":"J\u00a0Trop Med Hyg"},{"key":"10.1016\/j.jiac.2017.09.002_bib123","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1258\/ijsa.2009.009264","article-title":"Metronidazole treatment for acute phase amoebic liver abscess in patients co-infected with HIV","volume":"23","author":"Ohnishi","year":"2012","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jiac.2017.09.002_bib124","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.parint.2014.05.006","article-title":"Subjective adverse reactions to metronidazole in patients with amebiasis","volume":"63","author":"Ohnishi","year":"2014","journal-title":"Parasitol Int"},{"key":"10.1016\/j.jiac.2017.09.002_bib125","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4269\/ajtmh.2007.77.381","article-title":"Experience with intravenous metronidazole to treat moderate-to-severe amebiasis in Japan","volume":"77","author":"Kimura","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jiac.2017.09.002_bib126","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0924-8579(96)00327-5","article-title":"Treatment of symptomatic amebic colitis in human immunodeficiency virus-infected persons","volume":"7","author":"Ohnishi","year":"1996","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2017.09.002_bib127","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4269\/ajtmh.1979.28.19","article-title":"Giardiasis in infancy and childhood: a prospective study of 160 cases with comparison of quinacrine (Atabrine) and metronidazole (Flagyl)","volume":"28","author":"Kavousi","year":"1979","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jiac.2017.09.002_bib128","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/CMR.14.1.114-128.2001","article-title":"Treatment of giardiasis","volume":"14","author":"Gardner","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2017.09.002_bib129","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4269\/ajtmh.1997.56.637","article-title":"Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa","volume":"56","author":"Doumbo","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jiac.2017.09.002_bib130","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1086\/515352","article-title":"Combination drug therapy for cryptosporidiosis in AIDS","volume":"178","author":"Smith","year":"1998","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib131","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1001\/jama.299.16.1937","article-title":"Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis","volume":"299","author":"Keiser","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2017.09.002_bib132","first-page":"618","article-title":"Studies on the control of hookworm and other soil-transmitted helminthiasis in farmers in Zhejiang Province, China","volume":"22","author":"Xia","year":"1991","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.jiac.2017.09.002_bib133","first-page":"777","article-title":"Mebendazole in the treatment of helminthiasis","volume":"115","author":"Seah","year":"1996","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jiac.2017.09.002_bib134","first-page":"161","article-title":"A\u00a0clinical evaluation of mebendazole on Trichuriasis in Japan","volume":"61","author":"Tanabe","year":"1987","journal-title":"J\u00a0Jpn Assoc Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib135","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1517\/14656566.2.2.267","article-title":"Chemotherapy of enterobiasis (oxyuriasis)","volume":"2","author":"St Georgiev","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jiac.2017.09.002_bib136","first-page":"520","article-title":"Albendazole in Japanese juvenile with enterobiasis in whom pyrantel pamoate is not effective","volume":"85","author":"Ohnishi","year":"2011","journal-title":"J\u00a0Jpn Assoc Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib137","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4269\/ajtmh.1989.40.304","article-title":"Ivermectin for human strongyloidiasis and other intestinal helminthes","volume":"40","author":"Naquira","year":"1989","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jiac.2017.09.002_bib138","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s101560200013","article-title":"Efficacy of ivermectin for chronic strongyloidiasis: two single doses given 2 weeks apart","volume":"8","author":"Zaha","year":"2002","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2017.09.002_bib139","doi-asserted-by":"crossref","first-page":"e1254","DOI":"10.1371\/journal.pntd.0001254","article-title":"Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis","volume":"5","author":"Bisoffi","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib140","first-page":"246","article-title":"Treatment of Opisthorchis viverrini and intestinal fluke infections with praziquantel","volume":"29","author":"Pungpak","year":"1998","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.jiac.2017.09.002_bib141","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3347\/kjp.2009.47.3.315","article-title":"Egg laying capacity of Haplorchis taichui (Digenea: Heterophydae) in humans","volume":"47","author":"Sato","year":"2009","journal-title":"Korean J Parasitol"},{"key":"10.1016\/j.jiac.2017.09.002_bib142","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0035-9203(93)90049-V","article-title":"Single dose treatment with praziquantel for human Diphyllobothrium nihonkaiense infections","volume":"87","author":"Ohnishi","year":"1993","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"10.1016\/j.jiac.2017.09.002_bib143","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2169\/internalmedicine.42.41","article-title":"Single low-dose treatment with praziquantel for Diphyllobothrium nihonkaiense infections","volume":"42","author":"Ohnishi","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib144","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/00034983.1990.11812513","article-title":"Effectiveness of praziquantel against Taenia saginata infections in Ethiopia","volume":"84","author":"Tsfa-Yohannes","year":"1990","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.jiac.2017.09.002_bib145","first-page":"303","article-title":"Successful treatment of Taenia saginata and Hymenolepsis nana by single oral dose of praziquantel","volume":"21","author":"Bouree","year":"1991","journal-title":"J\u00a0Egypt Soc Parasitol"},{"key":"10.1016\/j.jiac.2017.09.002_bib146","doi-asserted-by":"crossref","first-page":"e656","DOI":"10.1016\/j.ijid.2013.02.028","article-title":"Therapeutic effect of praziquantel against taeniasis asiatica","volume":"17","author":"Ohnishi","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib147","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.4315\/0362-028X.JFP-10-387","article-title":"Estimating the burden of acute gastroenteritis and foodborne illness caused by Campylobacter, Salmonella, and Vibrio parahaemolyticus by using population-based telephone survey data, Miyagi Prefecture, Japan, 2005 to 2006","volume":"74","author":"Kubota","year":"2011","journal-title":"J\u00a0Food Prot"},{"key":"10.1016\/j.jiac.2017.09.002_bib148","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/INF.0b013e31827ca763","article-title":"Estimates of illnesses, hospitalizations and deaths caused by major bacterial enteric pathogens in young children in the United States","volume":"32","author":"Scallan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2017.09.002_bib149","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3109\/00365549409008624","article-title":"Encephalopathy associated with Salmonella enteritidis infection","volume":"26","author":"Martin","year":"1994","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib150","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/INF.0b013e318166356c","article-title":"Proinflammatory cytokines in cerebrospinal fluid from patients with nontyphoidal Salmonella encephalopathy","volume":"27","author":"Imamura","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2017.09.002_bib151","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1086\/318457","article-title":"Nontyphoidal salmonellosis","volume":"32","author":"Hohmann","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib152","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1086\/644621","article-title":"Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006","volume":"49","author":"Gould","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib153","series-title":"The Team for the Preparation of the Guidelines for the diagnosis\/treatment of hemolytic-uremic syndrome","year":"2014"},{"key":"10.1016\/j.jiac.2017.09.002_bib154","series-title":"The 54th Japanese association of medical technologists Kinki branch medical test conference","first-page":"160","article-title":"Rapid diagnosis of campylobacter enteritis Physician-technician cooperation","author":"Yamamoto","year":"2014"},{"key":"10.1016\/j.jiac.2017.09.002_bib155","first-page":"408","article-title":"Campylobacter enteritis in children in northern Taiwan\u2013a 7-year experience","volume":"41","author":"Wang","year":"2008","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.jiac.2017.09.002_bib156","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/00365540903283723","article-title":"Antimicrobial susceptibility of clinical Campylobacter isolates collected at a German university hospital during the period 2006-2008","volume":"42","author":"Valenza","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib157","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s10156-008-0631-2","article-title":"Antimicrobial susceptibility and mechanism of quinolone resistance in Campylobacter jejuni strains isolated from diarrheal patients in a hospital in Tokyo","volume":"14","author":"Bakeli","year":"2008","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2017.09.002_bib158","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1128\/AAC.39.2.542","article-title":"Susceptibilities of fluoroquinolone-resistant strains of Campylobacter jejuni to 11 oral antimicrobial agents","volume":"39","author":"Gomez-Garces","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.09.002_bib159","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1128\/AAC.01333-10","article-title":"Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: national antimicrobial resistance monitoring system, 1996 to 2007","volume":"55","author":"Crump","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.09.002_bib160","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1097\/INF.0b013e31825894b0","article-title":"Invasive salmonellosis in urban Thai children: a ten-year review","volume":"31","author":"Punpanich","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2017.09.002_bib161","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0149-2918(02)80062-5","article-title":"Results of a 5-year prospective surveillance study of antibiotic resistance among Salmonella enterica isolates and ceftriaxone therapy among children hospitalized for acute diarrhea","volume":"24","author":"Chiappini","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.jiac.2017.09.002_bib162","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3201\/eid\/1706.101949","article-title":"Increasing ceftriaxone resistance in salmonellae, Taiwan","volume":"17","author":"Su","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib163","first-page":"518","article-title":"Nontyphoid salmonellosis in Taiwan children: clinical manifestations, outcome and antibiotic resistance","volume":"38","author":"Huang","year":"2004","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jiac.2017.09.002_bib164","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1469-0691.2011.03552.x","article-title":"Treatment of typhoid fever in the 21st century: promises and shortcomings","volume":"17","author":"Butler","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2017.09.002_bib165","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b1865","article-title":"A\u00a0comparison of fluoroquinolones versus other antibiotics for treating enteric fever: meta-analysis","volume":"338","author":"Thaver","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jiac.2017.09.002_bib166","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/jama.2009.1229","article-title":"Typhoid fever in the United States, 1999-2006","volume":"302","author":"Lynch","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2017.09.002_bib167","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1365-2036.2006.03036.x","article-title":"Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection?","volume":"24","author":"Panos","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jiac.2017.09.002_bib168","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/INF.0b013e31823096a8","article-title":"Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota","volume":"31","author":"Smith","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2017.09.002_bib169","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/jama.288.8.1014","article-title":"Antimicrobial therapy in patients with Escherichia coli O157:H7 infection","volume":"288","author":"M\u00f8lbak","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2017.09.002_bib170","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1442-200X.1999.4121041.x","article-title":"Clinical experiences in Sakai city hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai city, 1996","volume":"41","author":"Fukushima","year":"1999","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jiac.2017.09.002_bib171","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1086\/499236","article-title":"Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh","volume":"42","author":"Bennish","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib172","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1128\/AAC.50.1.49-54.2006","article-title":"High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002","volume":"50","author":"Sivapalasingam","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.09.002_bib173","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijantimicag.2005.12.008","article-title":"Antibiotic susceptibilities of Yersinia enterocolitica recovered from children over a 12-year period","volume":"27","author":"Abdel-Haq","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2017.09.002_bib174","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00006454-198810000-00003","article-title":"Ampicillin vs. placebo for Yersinia pseudotuberculosis infection in children","volume":"7","author":"Sato","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2017.09.002_bib175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/0470846534.ch2","article-title":"Gastroenteritis viruses: an overview","volume":"238","author":"Glass","year":"2001","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.jiac.2017.09.002_bib176","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/infdis\/162.3.598","article-title":"Impact of rotavirus infection at a large pediatric hospital","volume":"162","author":"Matson","year":"1990","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib177","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJM199610033351404","article-title":"Rotavirus infections in infants as protection against subsequent infections","volume":"335","author":"Vel\u00e1zquez","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib178","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0140-6736(97)10322-1","article-title":"Role of human-milk lactadherin in protection against symptomatic rotavirus infection","volume":"351","author":"Newburg","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2017.09.002_bib179","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0022-3476(77)80810-X","article-title":"Clinical features of acute gastroenteritis associated with human reovirus-like agent in infants and young children","volume":"91","author":"Rodriguez","year":"1977","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jiac.2017.09.002_bib180","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00006454-200203000-00012","article-title":"Clinical presentations of rotavirus infection among hospitalized children","volume":"21","author":"Staat","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2017.09.002_bib181","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/jmv.10449","article-title":"Viral agents of acute gastroenteritis in German children: prevalence and molecular diversity","volume":"71","author":"Oh","year":"2003","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jiac.2017.09.002_bib182","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/jmv.10347","article-title":"Epidemiological features of rotavirus infection among hospitalized children with gastroenteristis in Ho Chi Minh City, Vietnam","volume":"69","author":"Doan","year":"2003","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jiac.2017.09.002_bib183","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0928-8244(01)00310-8","article-title":"Incidence of Norwalk-like viruses, rotavirus and adenovirus infection in patients with acute gastroenteritis in Jakarta, Indonesia","volume":"33","author":"Subekti","year":"2002","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.jiac.2017.09.002_bib184","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/jmv.10146","article-title":"Circulation of the novel G9 and G8 rotavirus strains in Nigeria in 1998\/1999","volume":"67","author":"Steele","year":"2002","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jiac.2017.09.002_bib185","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1542\/peds.97.3.424","article-title":"Practice parameter: the management of acute gastroenteritis in young children. American academy of pediatrics, provisional committee on quality improvement, Subcommittee on acute gastroenteritis","volume":"97","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.jiac.2017.09.002_bib186","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1542\/peds.98.1.45","article-title":"Efficacy of glucose-based oral rehydration therapy","volume":"98","author":"Gavin","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.jiac.2017.09.002_bib187","first-page":"S81","article-title":"European society for paediatric gastroenterology, Hepatology, and nutrition\/European society for paediatric infectious diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe","volume":"46","author":"Guarino","year":"2008","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jiac.2017.09.002_bib188","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1001\/jama.1988.03410220065029","article-title":"Diarrheal deaths in American children. Are they preventable?","volume":"260","author":"Ho","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2017.09.002_bib189","first-page":"1","article-title":"Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy","volume":"52","author":"King","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jiac.2017.09.002_bib190","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bmj.290.6468.587","article-title":"Effect on clinical outcome of breast feeding during acute diarrhoea","volume":"290","author":"Khin","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jiac.2017.09.002_bib191","first-page":"224","article-title":"Clinical trial of home available, mixed diets versus a lactose-free, soy-protein formula for the dietary management of acute childhood diarrhea","volume":"12","author":"Alarcon","year":"1991","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jiac.2017.09.002_bib192","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1542\/peds.93.1.17","article-title":"Use of nonhuman milks in the dietary management of young children with acute diarrhea: a meta-analysis of clinical trials","volume":"93","author":"Brown","year":"1994","journal-title":"Pediatrics"},{"key":"10.1016\/j.jiac.2017.09.002_bib193","first-page":"340","article-title":"Clinical trial of modified whole milk, lactose-hydrolyzed whole milk, or cereal-milk mixtures for the dietary management of acute childhood diarrhea","volume":"12","author":"Brown","year":"1991","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jiac.2017.09.002_bib194","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/gast.2001.27178","article-title":"Clinical studies in persistent diarrhea: dietary management with green banana or pectin in Bangladeshi children","volume":"121","author":"Rabbani","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jiac.2017.09.002_bib195","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/jama.1979.03290310041015","article-title":"Toxic megacolon associated with loperamide therapy","volume":"241","author":"Brown","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2017.09.002_bib196","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/adc.54.3.222","article-title":"Lomotil poisoning in children","volume":"54","author":"Curtis","year":"1979","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jiac.2017.09.002_bib197","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040098","article-title":"Loperamide therapy for acute diarrhea in children: systematic review and meta-analysis","volume":"4","author":"Li","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib198","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0022-3476(81)80285-5","article-title":"Absorption of salicylate and bismuth from a bismuth subsalicylate\u2013containing compound (Pepto-Bismol)","volume":"99","author":"Pickering","year":"1981","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jiac.2017.09.002_bib199","article-title":"Probiotics for treating acute infectious diarrhoea","volume":"11","author":"Allen","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jiac.2017.09.002_bib200","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1542\/peds.109.4.678","article-title":"Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis","volume":"109","author":"Van Niel","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.jiac.2017.09.002_bib201","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1097\/MCG.0b013e31816fc2f6","article-title":"Use of VSL#3 in the treatment of rotavirus diarrhea in children: preliminary results","volume":"42","author":"Dubey","year":"2008","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jiac.2017.09.002_bib202","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ijid.2008.09.014","article-title":"Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children","volume":"13","author":"Teran","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.002_bib203","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/tropej\/fmp001","article-title":"Dose-dependent effect of Lactobacillus rhamnosus on quantitative reduction of faecal rotavirus shedding in children","volume":"55","author":"Fang","year":"2009","journal-title":"J\u00a0Trop Pediatr"},{"key":"10.1016\/j.jiac.2017.09.002_bib204","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archpedi.162.9.858","article-title":"Use of antiemetic agents in acute gastroenteritis: a systematic review and meta-analysis","volume":"162","author":"DeCamp","year":"2008","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib205","first-page":"452","article-title":"Diverse effects of antiemetics in children","volume":"107","author":"Carey","year":"1994","journal-title":"N\u00a0Z Med J"},{"key":"10.1016\/j.jiac.2017.09.002_bib206","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1056\/NEJMoa055119","article-title":"Oral ondansetron for gastroenteritis in a pediatric emergency department","volume":"354","author":"Freedman","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib207","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.annemergmed.2007.09.010","article-title":"The role of oral ondansetron in children with vomiting as a result of acute gastritis\/gastroenteritis who have failed oral rehydration therapy: a randomized controlled trial","volume":"52","author":"Roslund","year":"2008","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib208","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/adc.77.3.196","article-title":"Randomised controlled trial of zinc supplementation in malnourished Bangladeshi children with acute diarrhoea","volume":"77","author":"Roy","year":"1997","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jiac.2017.09.002_bib209","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJM199509283331304","article-title":"Zinc supplementation in young children with acute diarrhea in India","volume":"333","author":"Sazawal","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.09.002_bib210","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005436.pub3","article-title":"Oral zinc for treating diarrhoea in children","volume":"6","author":"Lazzerini","year":"2012","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17302040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17302040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:57:24Z","timestamp":1761159444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X17302040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":210,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1341321X17302040"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2017.09.002","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"JAID\/JSC Guidelines for Infection Treatment 2015\u2212Intestinal infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2017.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}